Position in ZTS
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$410,069
-$549,560 QoQ
Shares Held
3,469
-54.5% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2020
24 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in ZTS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026Tower Research Capital LLC (TRC) holds $6,300,576 across 59 Drug Manufacturers - Specialty & Generic names. ZTS ranks #6 (6.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | UTHR |
UNITED THERAPEUTICS Corp
|
1,684 | $998,578 | |
| 2 | ALKS |
Alkermes plc.
|
16,120 | $570,003 | |
| 3 | NBIX |
Neurocrine Biosciences Inc
|
4,070 | $536,181 | |
| 4 | ELAN |
Elanco Animal Health Inc
|
19,404 | $464,337 | |
| 5 | LNTH |
Lantheus Holdings, Inc.
|
6,000 | $455,100 | |
| 6 | ZTS |
Zoetis Inc.
This page
|
3,469 | $410,069 | |
| 7 | HIMS |
Hims & Hers Health, Inc.
|
16,717 | $347,044 | |
| 8 | BCRX |
Biocryst Pharmaceuticals Inc
|
23,887 | $227,404 |
All Filings in ZTS
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $410,069 | 3,469 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $959,629 | 7,627 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $1,437,300 | 9,823 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $2,723,822 | 17,466 | Shares | Defined | 2025-08-15 | |
| 2025-03-31 | $3,007,826 | 18,268 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $3,906,897 | 23,979 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $2,305,679 | 11,801 | Shares | Other | 2024-11-14 | |
| 2024-06-30 | $4,102,044 | 23,662 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $2,575,883 | 15,223 | Shares | Other | 2024-05-15 | |
| 2023-12-31 | $12,880,168 | 65,259 | Shares | Other | 2024-02-13 | |
| 2023-09-30 | $3,373,124 | 19,388 | Shares | Other | 2023-11-14 | |
| 2023-06-30 | $2,660,643 | 15,450 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $1,492,466 | 8,967 | Shares | Other | 2023-05-09 | |
| 2022-12-31 | $1,239,959 | 8,461 | Shares | Other | 2023-02-10 | |
| 2022-09-30 | $6,673,494 | 45,003 | Shares | Other | 2022-11-10 | |
| 2022-06-30 | $3,895,714 | 22,664 | Shares | Other | 2022-08-15 | |
| 2022-03-31 | $13,432,699 | 71,227 | Shares | Other | 2022-05-12 | |
| 2021-12-31 | $7,386,299 | 30,268 | Shares | Other | 2022-02-14 | |
| 2021-09-30 | $2,915,788 | 15,019 | Shares | Other | 2021-11-15 | |
| 2021-06-30 | $1,151,518 | 6,179 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $6,393,372 | 40,598 | Shares | Other | 2021-05-17 | |
| 2020-12-31 | $1,842,842 | 11,135 | Shares | Other | 2021-02-16 | |
| 2020-09-30 | $2,058,855 | 12,450 | Shares | Defined | 2020-11-16 | |
| 2020-06-30 | $6,395,655 | 46,670 | Shares | Other | 2020-08-13 | |
| No filing history on record for this holder in this stock. | ||||||